Business Wire

NEC-CORPORATION

Share
NEC Face Recognition Technology Ranks First in NIST Accuracy Testing

NEC Corporation (NEC; TOKYO: 6701), a leader in the integration of IT and network technologies, today announced that its face recognition technology achieved the highest matching accuracy in the Face Recognition Vendor Test (FRVT) 2018 (*1) performed by the U.S. National Institute of Standards and Technology (NIST), with an error rate of 0.5% when registering 12 million people (*2).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191002005914/en/

NEC’s technology ranked No. 1 in NIST testing for the fifth time, following its top placement in the face recognition testing for video in 2017. The high performance of NEC’s technology is reflected in the test results which placed the company significantly ahead of the runner-up.

In recent years, the growing convenience of biometric authentication technology, improved security awareness, and the remarkable development of artificial intelligence (AI), have driven companies around the world to begin adopting biometric authentication technology. Specifically, the use of face recognition technology is rapidly expanding across a wide range of fields throughout the world. Face recognition technologies are now being used in areas that require high reliability, convenience and long-term use, such as identity verification and national infrastructure, transaction settlements, bank account establishment, and passport verification.

49 organizations, including companies from the United States, China, Russia, Europe, and Japan, participated in the NIST’s FRVT 2018, where the evaluation of face recognition accuracy was performed. These tests are the most rigorous and fair benchmarks implemented by the NIST as each organization is required to submit and be evaluated on programs that were developed during the same period. By performing multi-stage matching, an impressive search speed of 230 million matchings per second was achieved. Furthermore, leveraging NEC's deep learning methods to significantly reduce the identification error rate, NEC accurately matched images of a subject taken over a 10 year interval with an error rate that was 4 times lower than the runner-up.

Going forward, NEC aims to further expand the scope of this technology’s application to include store transaction settlements, services in public facilities, such as buses, railways, airports, city offices, and hospitals; and helping to protect and care for children and the elderly. Based on the NEC Group AI and Human Rights Principles established in April of this year (*3), NEC gives top priority to the consideration of privacy and respect for human rights when using AI and biometric data. NEC also aims to contribute to further improvements in the usability of biometric identification and video analytics technology, including face recognition.

“NEC’s portfolio of biometric identification solutions, ‘Bio-IDiom’ (*4), which includes face recognition technology, is critical to the ways that NEC is helping to build safer and more productive societies as part of the ‘NEC Value Chain Innovation’,” said Hitoshi Imaoka, NEC Fellow at NEC Corporation. “These technologies create new value by sharing information on the status of communities, things, and processes across the entire value chain, and are a meaningful source of growth in our Mid-term Management Plan 2020 and ‘NEC Safer Cities’ (*5), which support the realization of safe, secure, efficient, and equal cities.”

Notes :

(*1)

The Face Recognition Vendor Test 2018 (FRVT 2018), sponsored by the US Department of Homeland Security and others, assessed the accuracy and speed of authentication for tens of millions of people using face recognition technologies from top vendors from throughout the world.

https://www.nist.gov/programs-projects/frvt-1n-identification

 

(*2)

Patrick Grother, Mei Ngan, Kayee Hanaoka, Face Recognition Vendor Test (FRVT), NIST Interagency Report 8271(2019/09/11)

https://www.nist.gov/sites/default/files/documents/2019/09/11/nistir_8271_20190911.pdf

 

(*3)

NEC Unveils "NEC Group AI and Human Rights Principles"

https://www.nec.com/en/press/201904/global_20190402_01.html

 

(*4)

Bio-IDiom

https://www.nec.com/en/global/solutions/biometrics/index.html

 

(*5)

NEC Safer Cities

https://www.nec.com/en/global/solutions/safercities/index.html

About NEC Corporation
For more information, visit NEC at http://www.nec.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release

Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management

Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release

Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release

- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc

Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release

IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye